Seven Bridges Stock

sevenbridges.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $45MM

Seven Bridges is a provider of unified bioinformatics solutions accelerating precision medicine by enabling the understanding of biomedical data.

Register for Details

For more details on financing and valuation for Seven Bridges, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Seven Bridges.

Register Today

Seven Bridges investors also invested in these private companies

Kryssen Capital

Team

Management Team

Igor Bogicevic
Co-Founder and Chief Technology Officer
Mladen Srdic
Chief Technology Officer
Milan Mitrovic
Chief Product Officer
James Sietstra
President and Board Member
Robert Shay
Chief Financial Officer
Brian Castagna
Chief Information Security Officer
Brandi Davis-Dusenbery Ph.D
Chief Scientific Officer
Mike Bigda
Chief Operating Officer
William Moss
Chief Executive Officer
Bruce Press
Chief Revenue Officer

Board Members

James Sietstra

Other companies like Seven Bridges in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Seven Bridges Genomics to Foster Partnerships Between Health Systems, Pharmas With New Subsidiary
The Unified Patient Network expects pharmaceutical companies to sponsor whole-genome sequencing for patients from health systems for research and clinical purposes.
Seven Bridges Raises $15M in First Closing of Series C
Seven Bridges, E-Nios Partner to Automate Biomarker Extraction From NGS Data
With their strategic partnership, the bioinformatics firms seek to "break the biomarker bottleneck" that is holding back the potential of multi-omics research.
Updated on: Sep 23, 2023